About this episode
Five young mothers in Kota died within twelve days after a routine oxytocin shot. The vials meant to stop bleeding after childbirth had no drug in them at all, just water. What followed was an investigation that tore open a Punjab manufacturer's records: fabricated test data, tampered machines, missing safety checks, and a company that had been ordered to stop production three years ago and simply ignored it. Reported by Teena Thacker narrated by Anirban Chowdhury this epiosde traces the deaths, the daily-wage families left behind, and how a tiny, poorly regulated oxytocin market let a repeat offender keep supplying hospitals until it turned fatal.
Listen in.
You can follow Anirban Chowdhury on his social media: X and Linkedin and follow Teena Thacker on X and Linkedin
Check out other interesting episodes like:ET Deep Dive: Swipe Left on Reality,India wants manufacturing at 25% of GDP — will AI in factories help?, Tanay Kothari Wants To Kill The Keyboard, From Doer to Director: The LinkedIn Playbook for the AI Agea, Semaglutide Goes Generic: Big Pharma’s Moat Breaks and much more.
Catch the latest episode of ‘The Morning Brief’ on The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Youtube.
See omnystudio.com/listener for privacy information.
Get every episode summarized
Each time The Morning Brief publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Morning Brief
J.P.Morgan’s Anu Aiyengar on Mega Deals, AI’s Banking Reset and the India Bet
The Morning Brief
ET Deep Dive: When Development Turns Disaster
The Morning Brief
Subrata Mitra on India’s VC Reset, the AI Capital Race and What Comes Next
The Morning Brief
HDFC Bank’s CEO Hunt
The Morning Brief